Axogen Completes Acquisition of BioCircuit Technologies, Adding NerveTape
Axogen, Inc. (Nasdaq: AXGN) has successfully completed its acquisition of BioCircuit Technologies. This acquisition adds NerveTape, described as the first FDA-cleared device for sutureless peripheral nerve repair, to Axogen's portfolio.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.